Cingulate CINGW
NASDAQ CINGW
$0.01 +0.00 (+4.29%)
As of: Sep 9, 2026 · 11:16 AM EDT

Cingulate (CINGW) Cash from Operations (2021 - 2025)

Cingulate's (CINGW) quarterly Cash from Operations came in at -$3.6 million in Q4 2025, up 11.82% on a YoY basis from -$3.2 million in Q4 2024, and up 15.25% quarter-over-quarter from -$4.2 million in Q3 2025.

Analysis

Cingulate (CINGW) Cash from Operations (2021 - 2025) Analysis & Trends

Cingulate (CINGW) has reported Cash from Operations for 5 consecutive years, with -$3.6 million the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations rose 11.82% year-over-year to -$3.6 million; the trailing twelve-month figure through Dec 2025 stood at -$17.2 million (up 6.54% YoY), and the FY2025 full-year result was -$17.2 million, up 6.54% from the prior year.
  • Cash from Operations grew to -$3.6 million in Q4 2025 per CINGW's latest filing, from -$4.2 million in the prior quarter.
  • Across five years, Cash from Operations topped out at -$1.6 million in Q2 2021 and bottomed at -$8.7 million in Q1 2024.
  • Historically, Cash from Operations has averaged -$3.9 million across 5 years, with a median of -$4.0 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Cash from Operations slumped 184.53% in 2022, then jumped 62.16% in 2024.
  • Over 5 years, Cash from Operations stood at -$4.6 million in 2021, then rose by 9.0% to -$4.2 million in 2022, then jumped by 39.09% to -$2.6 million in 2023, then sank by 59.21% to -$4.1 million in 2024, then advanced by 11.82% to -$3.6 million in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods registered -$3.6 million, -$4.2 million, and -$4.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Operations (Qtr)
1 Johnson & Johnson 644.46 Bn 623.70 Bn 17.26 Bn 8.62 Bn
2 AbbVie 440.11 Bn 433.54 Bn 12.70 Bn 3.44 Bn
3 Merck 365.04 Bn 357.90 Bn 12.21 Bn 5.37 Bn
4 Novartis Ag 266.82 Bn 259.13 Bn 11.24 Bn 5.88 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn 835.00 Mn
6 Sanofi 52.47 Bn 45.09 Bn 10.79 Bn 3.44 Bn
7 Revolution Medicines 44.26 Bn 44.26 Bn - -387.32 Mn
8 Incyte 25.32 Bn 20.79 Bn 1.57 Bn 507.66 Mn
9 United Therapeutics 21.46 Bn 18.80 Bn 683.80 Mn 313.60 Mn
10 Cingulate 100,214.03 100,214.03 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -3.60 Mn
Sep 30, 2025 -4.24 Mn
Jun 30, 2025 -4.80 Mn
Mar 31, 2025 -4.61 Mn
Dec 31, 2024 -4.08 Mn
Sep 30, 2024 -3.88 Mn
Jun 30, 2024 -1.74 Mn
Mar 31, 2024 -8.75 Mn
Dec 31, 2023 -2.56 Mn
Sep 30, 2023 -4.29 Mn
Jun 30, 2023 -4.60 Mn
Mar 31, 2023 -3.58 Mn
Dec 31, 2022 -4.21 Mn
Sep 30, 2022 -3.40 Mn
Jun 30, 2022 -4.41 Mn
Mar 31, 2022 -3.86 Mn
Dec 31, 2021 -4.62 Mn
Sep 30, 2021 -2.59 Mn
Jun 30, 2021 -1.55 Mn
Mar 31, 2021 -1.67 Mn